Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Immediate priority: Patient safety and full, rapid compliance with legal/regulatory obligations over short-term stock price or board pressure. Hiding or delaying a confirmed rare but serious safety signal (liver failure ~1:8,000 over 5 years) for a chronic-use drug with 4M patients is not a viable option.Read the full answer
48-Hour Action Plan: Responsible Disclosure of Serious Adverse Effect FOUNDATIONAL PRINCIPLE Before the hour-by-hour breakdown, the strategic and ethical framework must be established clearly: proactive, transparent disclosure is the only viable path.Read the full answer